FDA warns teething medicines are unsafe, wants them off shelves
WKRN News 2-13 hours ago
Orajel is displayed for sale in a pharmacy in New York Wednesday, May 23, 2018. (AP Photo/Stephanie Nano). FDA warns teething medicines are unsafe, ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
|
05/09/2018 | Montana Compounding Pharmacy PC | Los Angeles District Office | Compounding Pharmacy/Adulterated Drug Products | Not Issued |
05/09/2018 | Nox Bellcow Cosmetics Co. Ltd. | Center for Drug Evaluation and Research | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued |
05/15/2018 | Cerno Pharmaceutical | Dallas District Office | CGMP/Finished Pharmaceuticals/Adulterated | Not Issued * |
05/18/2018 | Front Range Kratom | Center for Drug Evaluation and Research | Unapproved New Drug/Misbranded | Not Issued * |
05/18/2018 | Pharmacy Direct, PDU | Center for Food Safety and Applied Nutrition | New Drug/Labeling/Misbranded | Not Issued |
05/18/2018 | GliSODin Skin Nutrients | Center for Food Safety and Applied Nutrition | New Drug/Labeling/Misbranded | Not Issued * |
05/18/2018 | Revibe, Inc. | Center for Drug Evaluation and Research | Unapproved New Drug/Misbranded | Not Issued * |
05/18/2018 | Kratom Spot | Center for Drug Evaluation and Research | Unapproved New Drug/Misbranded | Not Issued * |
05/18/2018 | Sunergized LLC | Center for Food Safety and Applied Nutrition | New Drug/Labeling/Misbranded | Not Issued * |
|
Posted: 21 May 2018 07:38 PM PDT
On May 16, 2018, Vermont Governor Phil Scott signed Senate Bill 175, which allows for the wholesale importation of prescription drugs from Canada into Vermont. The new law directs the Vermont Agency of Human Services (VAHS) to design a wholesale prescription drug importation program that complies with federal drug importation laws (21 U.S.C. § 384), including requirements for safety and cost savings. The program must:
|